Free Trial
OTCMKTS:SARTF

SARTORIUS (SARTF) Stock Price, News & Analysis

SARTORIUS logo
$187.87 -2.13 (-1.12%)
As of 08/22/2025 10:13 AM Eastern

About SARTORIUS Stock (OTCMKTS:SARTF)

Key Stats

Today's Range
$187.87
$187.87
50-Day Range
$182.86
$208.82
52-Week Range
$165.00
$243.35
Volume
1 shs
Average Volume
9 shs
Market Capitalization
N/A
P/E Ratio
114.56
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Strong Buy

Company Overview

Receive SARTF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SARTORIUS and its competitors with MarketBeat's FREE daily newsletter.

SARTF Stock News Headlines

SARTORIUS (OTCMKTS:SARTF) and CVRx (NASDAQ:CVRX) Financial Analysis
Trump’s national nightmare is here
Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.tc pixel
See More Headlines

SARTF Stock Analysis - Frequently Asked Questions

SARTORIUS's stock was trading at $184.00 on January 1st, 2025. Since then, SARTF shares have increased by 2.1% and is now trading at $187.87.

SARTORIUS (OTCMKTS:SARTF) posted its quarterly earnings results on Tuesday, July, 22nd. The company reported $1.38 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.49 by $0.11. The company earned $1.04 billion during the quarter, compared to analyst estimates of $977.90 million. SARTORIUS had a net margin of 3.00% and a trailing twelve-month return on equity of 7.79%.

The following companies are subsidiaries of SARTORIUS: Novasep’s chromatography division, ALS Automated Lab Solutions GmbH, Xell AG, CellGenix Inc., WaterSep BioSeparations LLC, BIA Separations, Biological Industries, and others.

Shares of SARTF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
7/22/2025
Today
8/24/2025
Next Earnings (Estimated)
10/16/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED INSTRUMENTS
Sub-Industry
N/A
Current Symbol
OTCMKTS:SARTF
Previous Symbol
NASDAQ:SARTF
CIK
N/A
Employees
13,528
Year Founded
1870

Profitability

EPS (Trailing Twelve Months)
$1.64
Trailing P/E Ratio
114.56
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$90.90 million
Net Margins
3.00%
Pretax Margin
6.67%
Return on Equity
7.79%
Return on Assets
2.98%

Debt

Debt-to-Equity Ratio
1.08
Current Ratio
1.39
Quick Ratio
0.88

Sales & Book Value

Annual Sales
$3.66 billion
Price / Sales
N/A
Cash Flow
$28.99 per share
Price / Cash Flow
6.48
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
1.02

Social Links

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (OTCMKTS:SARTF) was last updated on 8/24/2025 by MarketBeat.com Staff
From Our Partners